Cargando…

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape

Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an “arms race” between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheepers, Cathrine, Bekker, Valerie, Anthony, Colin, Richardson, Simone I., Oosthuysen, Brent, Moyo, Thandeka, Kgagudi, Prudence, Kitchin, Dale, Nonyane, Molati, York, Talita, Mielke, Dieter, Mabvakure, Batsirai M., Sheng, Zizhang, Lambson, Bronwen E., Ismail, Arshad, Garrett, Nigel J., Karim, Salim S. Abdool, Shapiro, Lawrence, Williamson, Carolyn, Morris, Lynn, Moore, Penny L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723817/
https://www.ncbi.nlm.nih.gov/pubmed/33238131
http://dx.doi.org/10.1016/j.celrep.2020.108430
_version_ 1783620422227460096
author Scheepers, Cathrine
Bekker, Valerie
Anthony, Colin
Richardson, Simone I.
Oosthuysen, Brent
Moyo, Thandeka
Kgagudi, Prudence
Kitchin, Dale
Nonyane, Molati
York, Talita
Mielke, Dieter
Mabvakure, Batsirai M.
Sheng, Zizhang
Lambson, Bronwen E.
Ismail, Arshad
Garrett, Nigel J.
Karim, Salim S. Abdool
Shapiro, Lawrence
Williamson, Carolyn
Morris, Lynn
Moore, Penny L.
author_facet Scheepers, Cathrine
Bekker, Valerie
Anthony, Colin
Richardson, Simone I.
Oosthuysen, Brent
Moyo, Thandeka
Kgagudi, Prudence
Kitchin, Dale
Nonyane, Molati
York, Talita
Mielke, Dieter
Mabvakure, Batsirai M.
Sheng, Zizhang
Lambson, Bronwen E.
Ismail, Arshad
Garrett, Nigel J.
Karim, Salim S. Abdool
Shapiro, Lawrence
Williamson, Carolyn
Morris, Lynn
Moore, Penny L.
author_sort Scheepers, Cathrine
collection PubMed
description Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an “arms race” between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodies to neutralize emerging viral escape variants. However, the Ig-constant region (which determines isotype) can also influence epitope recognition. Here, we use longitudinal deep sequencing of an HIV-directed nAb lineage, CAP88-CH06, and identify several co-circulating isotypes (IgG3, IgG1, IgA1, IgG2, and IgA2), some of which share identical variable regions. First, we show that IgG3 and IgA1 isotypes are better able to neutralize longitudinal autologous viruses and epitope mutants than can IgG1. Second, detrimental class-switch recombination (CSR) events that resulted in reduced neutralization can be rescued by further CSR, which we term “switch redemption.” Thus, CSR represents an additional immunological mechanism to counter viral escape from HIV-specific antibody responses.
format Online
Article
Text
id pubmed-7723817
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-77238172020-12-09 Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape Scheepers, Cathrine Bekker, Valerie Anthony, Colin Richardson, Simone I. Oosthuysen, Brent Moyo, Thandeka Kgagudi, Prudence Kitchin, Dale Nonyane, Molati York, Talita Mielke, Dieter Mabvakure, Batsirai M. Sheng, Zizhang Lambson, Bronwen E. Ismail, Arshad Garrett, Nigel J. Karim, Salim S. Abdool Shapiro, Lawrence Williamson, Carolyn Morris, Lynn Moore, Penny L. Cell Rep Article Neutralizing antibodies (nAbs) to highly variable viral pathogens show remarkable diversification during infection, resulting in an “arms race” between virus and host. Studies of nAb lineages have shown how somatic hypermutation (SHM) in immunoglobulin (Ig)-variable regions enables maturing antibodies to neutralize emerging viral escape variants. However, the Ig-constant region (which determines isotype) can also influence epitope recognition. Here, we use longitudinal deep sequencing of an HIV-directed nAb lineage, CAP88-CH06, and identify several co-circulating isotypes (IgG3, IgG1, IgA1, IgG2, and IgA2), some of which share identical variable regions. First, we show that IgG3 and IgA1 isotypes are better able to neutralize longitudinal autologous viruses and epitope mutants than can IgG1. Second, detrimental class-switch recombination (CSR) events that resulted in reduced neutralization can be rescued by further CSR, which we term “switch redemption.” Thus, CSR represents an additional immunological mechanism to counter viral escape from HIV-specific antibody responses. 2020-11-24 /pmc/articles/PMC7723817/ /pubmed/33238131 http://dx.doi.org/10.1016/j.celrep.2020.108430 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0).
spellingShingle Article
Scheepers, Cathrine
Bekker, Valerie
Anthony, Colin
Richardson, Simone I.
Oosthuysen, Brent
Moyo, Thandeka
Kgagudi, Prudence
Kitchin, Dale
Nonyane, Molati
York, Talita
Mielke, Dieter
Mabvakure, Batsirai M.
Sheng, Zizhang
Lambson, Bronwen E.
Ismail, Arshad
Garrett, Nigel J.
Karim, Salim S. Abdool
Shapiro, Lawrence
Williamson, Carolyn
Morris, Lynn
Moore, Penny L.
Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
title Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
title_full Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
title_fullStr Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
title_full_unstemmed Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
title_short Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
title_sort antibody isotype switching as a mechanism to counter hiv neutralization escape
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723817/
https://www.ncbi.nlm.nih.gov/pubmed/33238131
http://dx.doi.org/10.1016/j.celrep.2020.108430
work_keys_str_mv AT scheeperscathrine antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT bekkervalerie antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT anthonycolin antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT richardsonsimonei antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT oosthuysenbrent antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT moyothandeka antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT kgagudiprudence antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT kitchindale antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT nonyanemolati antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT yorktalita antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT mielkedieter antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT mabvakurebatsiraim antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT shengzizhang antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT lambsonbronwene antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT ismailarshad antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT garrettnigelj antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT karimsalimsabdool antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT shapirolawrence antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT williamsoncarolyn antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT morrislynn antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape
AT moorepennyl antibodyisotypeswitchingasamechanismtocounterhivneutralizationescape